NEW YORK (GenomeWeb News) – Fluidigm said this week it has completed its $207.5 million buy of mass cytometry firm DVS Sciences. Principally operating in Sunnyvale, Calif., DVS is now a wholly owned subsidiary of Fluidigm.
Registering provides access to this and other free content.
Already have an account?Login Now.
An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.
The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.
In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.